Skip to main content

Table 2 Total vaccine delivered, side effects, and complications

From: Prolonged intralymphatic delivery of dendritic cells through implantable lymphatic ports in patients with advanced cancer

Patient

No. of Treatment Courses

No. of DCs delivered (cells)

Side effects

Complications

1

3

6x106

None

Complication

Time of Complication (wks)

Loss of Catheter Patency

5

Loss of Catheter Patency

11

Hematoma with Cellulitis

10

2

4

8x106

None

Complication

Time of Complication (wks)

Cellulitis

1, 5, 10

Loss of Catheter Patency

10

Loss of Catheter Patency

16

3

3

6x106

None

Complication

Time of Complication (wks)

Cellulitis

2

Loss of Catheter Patency

3

4

4

8x106

Erythema

Complication

Time of Complication (wks)

Loss of Catheter Patency

13

5

2

4x106

Flushing during administration

Complication

Time of Complication (wks)

Hematoma

5

Loss of Catheter Patency

9

6

2

4x106

Flushing during administration

None

7

3

4.9x106

None

None

8

6

11.8x106

Erythema

Complication

Time of Complication (wks)

Failed Catheter Placement

0

9

4

8x106

Fatigue, Diarrhea

None